nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—pituitary gland—breast cancer	0.0238	0.221	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—adipose tissue—breast cancer	0.0237	0.22	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—female reproductive system—breast cancer	0.0217	0.203	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—female gonad—breast cancer	0.0198	0.184	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—endocrine gland—breast cancer	0.0184	0.171	CbGeAlD
Glycerol Phenylbutyrate—Headache—Letrozole—breast cancer	0.00184	0.0031	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Anastrozole—breast cancer	0.00184	0.0031	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Docetaxel—breast cancer	0.00182	0.00307	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Vinblastine—breast cancer	0.0018	0.00303	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Chlorambucil—breast cancer	0.00179	0.003	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Raloxifene—breast cancer	0.00177	0.00298	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Idarubicin—breast cancer	0.00177	0.00298	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Tamoxifen—breast cancer	0.00177	0.00298	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Capecitabine—breast cancer	0.00176	0.00297	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Idarubicin—breast cancer	0.00176	0.00296	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Raloxifene—breast cancer	0.00176	0.00296	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Raloxifene—breast cancer	0.00176	0.00296	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Idarubicin—breast cancer	0.00176	0.00296	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Tamoxifen—breast cancer	0.00175	0.00294	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Raloxifene—breast cancer	0.00175	0.00294	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Idarubicin—breast cancer	0.00175	0.00294	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Letrozole—breast cancer	0.00175	0.00294	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Anastrozole—breast cancer	0.00175	0.00294	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Tamoxifen—breast cancer	0.00174	0.00292	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Tamoxifen—breast cancer	0.00173	0.00292	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Melphalan—breast cancer	0.00173	0.00292	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Irinotecan—breast cancer	0.00171	0.00288	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Melphalan—breast cancer	0.00171	0.00288	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Melphalan—breast cancer	0.0017	0.00286	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Melphalan—breast cancer	0.0017	0.00286	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Vinblastine—breast cancer	0.00169	0.00285	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Goserelin—breast cancer	0.00169	0.00284	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Vinorelbine—breast cancer	0.00169	0.00284	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Goserelin—breast cancer	0.00167	0.00281	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Raloxifene—breast cancer	0.00166	0.00279	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Idarubicin—breast cancer	0.00166	0.00279	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Goserelin—breast cancer	0.00166	0.00279	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Tamoxifen—breast cancer	0.00164	0.00277	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Vinblastine—breast cancer	0.00164	0.00275	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Chlorambucil—breast cancer	0.00162	0.00273	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Thiotepa—breast cancer	0.00161	0.00271	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Capecitabine—breast cancer	0.0016	0.00269	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Tamoxifen—breast cancer	0.00159	0.00267	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Goserelin—breast cancer	0.00157	0.00264	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Chlorambucil—breast cancer	0.00155	0.0026	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Goserelin—breast cancer	0.00152	0.00255	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Vinorelbine—breast cancer	0.0015	0.00252	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Vinblastine—breast cancer	0.00149	0.0025	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Vinorelbine—breast cancer	0.00148	0.0025	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Vinorelbine—breast cancer	0.00148	0.00249	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Thiotepa—breast cancer	0.00145	0.00243	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Tamoxifen—breast cancer	0.00144	0.00243	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Chlorambucil—breast cancer	0.00144	0.00242	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Thiotepa—breast cancer	0.00143	0.0024	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Thiotepa—breast cancer	0.00142	0.00239	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Paclitaxel—breast cancer	0.00142	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Thiotepa—breast cancer	0.00142	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Vinblastine—breast cancer	0.00142	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Melphalan—breast cancer	0.00141	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Vinorelbine—breast cancer	0.00141	0.00237	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Paclitaxel—breast cancer	0.0014	0.00235	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Irinotecan—breast cancer	0.00139	0.00234	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Goserelin—breast cancer	0.00138	0.00232	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Tamoxifen—breast cancer	0.00138	0.00231	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Vinblastine—breast cancer	0.00137	0.0023	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Vinorelbine—breast cancer	0.00136	0.00229	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Gemcitabine—breast cancer	0.00136	0.00228	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Melphalan—breast cancer	0.00135	0.00227	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Thiotepa—breast cancer	0.00134	0.00226	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Chlorambucil—breast cancer	0.00134	0.00226	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Fluorouracil—breast cancer	0.00133	0.00224	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Tamoxifen—breast cancer	0.00133	0.00224	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Vinblastine—breast cancer	0.00132	0.00221	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Goserelin—breast cancer	0.00131	0.00221	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Thiotepa—breast cancer	0.0013	0.00218	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Vinblastine—breast cancer	0.0013	0.00218	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Tamoxifen—breast cancer	0.00128	0.00215	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Goserelin—breast cancer	0.00127	0.00214	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Tamoxifen—breast cancer	0.00127	0.00213	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Tamoxifen—breast cancer	0.00127	0.00213	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Tamoxifen—breast cancer	0.00126	0.00212	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Melphalan—breast cancer	0.00125	0.00211	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Mitoxantrone—breast cancer	0.00125	0.0021	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Irinotecan—breast cancer	0.00125	0.0021	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Melphalan—breast cancer	0.00124	0.00209	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Melphalan—breast cancer	0.00124	0.00209	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Vinorelbine—breast cancer	0.00123	0.00208	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Irinotecan—breast cancer	0.00123	0.00207	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Mitoxantrone—breast cancer	0.00123	0.00207	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Vinblastine—breast cancer	0.00123	0.00207	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Epirubicin—breast cancer	0.00123	0.00207	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Irinotecan—breast cancer	0.00122	0.00206	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Irinotecan—breast cancer	0.00122	0.00206	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Mitoxantrone—breast cancer	0.00122	0.00206	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Goserelin—breast cancer	0.00122	0.00205	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Goserelin—breast cancer	0.00121	0.00204	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Goserelin—breast cancer	0.00121	0.00204	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Goserelin—breast cancer	0.0012	0.00202	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Docetaxel—breast cancer	0.0012	0.00202	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Gemcitabine—breast cancer	0.0012	0.00202	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Fluorouracil—breast cancer	0.0012	0.00201	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Tamoxifen—breast cancer	0.00119	0.00201	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Gemcitabine—breast cancer	0.00119	0.00201	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Methotrexate—breast cancer	0.00119	0.002	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Gemcitabine—breast cancer	0.00119	0.002	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Fluorouracil—breast cancer	0.00118	0.00199	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Thiotepa—breast cancer	0.00118	0.00198	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Vinorelbine—breast cancer	0.00118	0.00198	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Fluorouracil—breast cancer	0.00117	0.00197	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Melphalan—breast cancer	0.00117	0.00197	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Capecitabine—breast cancer	0.00116	0.00196	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Irinotecan—breast cancer	0.00116	0.00195	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Mitoxantrone—breast cancer	0.00116	0.00195	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Capecitabine—breast cancer	0.00115	0.00193	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Goserelin—breast cancer	0.00114	0.00192	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Vinorelbine—breast cancer	0.00114	0.00191	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Doxorubicin—breast cancer	0.00114	0.00191	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Paclitaxel—breast cancer	0.00113	0.00191	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Thiotepa—breast cancer	0.00112	0.00189	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Irinotecan—breast cancer	0.00112	0.00189	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Mitoxantrone—breast cancer	0.00112	0.00189	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Vinorelbine—breast cancer	0.00109	0.00184	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Thiotepa—breast cancer	0.00109	0.00183	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Vinorelbine—breast cancer	0.00108	0.00182	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Vinorelbine—breast cancer	0.00108	0.00182	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Vinorelbine—breast cancer	0.00108	0.00181	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Thiotepa—breast cancer	0.00104	0.00176	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Thiotepa—breast cancer	0.00104	0.00174	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Thiotepa—breast cancer	0.00103	0.00174	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Thiotepa—breast cancer	0.00103	0.00173	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Vinorelbine—breast cancer	0.00102	0.00172	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Paclitaxel—breast cancer	0.00102	0.00171	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Irinotecan—breast cancer	0.00102	0.00171	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Mitoxantrone—breast cancer	0.00102	0.00171	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Paclitaxel—breast cancer	0.00101	0.00169	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000999	0.00168	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Paclitaxel—breast cancer	0.000997	0.00168	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Gemcitabine—breast cancer	0.000991	0.00167	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Thiotepa—breast cancer	0.000976	0.00164	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Irinotecan—breast cancer	0.000971	0.00163	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Mitoxantrone—breast cancer	0.000971	0.00163	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Docetaxel—breast cancer	0.000962	0.00162	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Paclitaxel—breast cancer	0.000946	0.00159	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Gemcitabine—breast cancer	0.000945	0.00159	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Irinotecan—breast cancer	0.000938	0.00158	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Capecitabine—breast cancer	0.000931	0.00157	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Fluorouracil—breast cancer	0.00093	0.00156	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Paclitaxel—breast cancer	0.000915	0.00154	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Irinotecan—breast cancer	0.000902	0.00152	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Mitoxantrone—breast cancer	0.000902	0.00152	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC2A2—breast cancer	0.000899	0.00302	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Fluorouracil—breast cancer	0.000898	0.00151	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Irinotecan—breast cancer	0.000894	0.0015	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Mitoxantrone—breast cancer	0.000894	0.0015	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Mitoxantrone—breast cancer	0.000894	0.0015	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Irinotecan—breast cancer	0.000894	0.0015	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GLI2—breast cancer	0.00089	0.00298	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VCP—breast cancer	0.00089	0.00298	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Irinotecan—breast cancer	0.000889	0.0015	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Mitoxantrone—breast cancer	0.000889	0.0015	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—MTR—breast cancer	0.000881	0.00295	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Gemcitabine—breast cancer	0.000879	0.00148	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LEPR—breast cancer	0.000876	0.00294	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Gemcitabine—breast cancer	0.000871	0.00147	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Gemcitabine—breast cancer	0.00087	0.00146	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Methotrexate—breast cancer	0.000866	0.00146	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Gemcitabine—breast cancer	0.000866	0.00146	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Fluorouracil—breast cancer	0.000864	0.00145	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Docetaxel—breast cancer	0.000863	0.00145	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Fluorouracil—breast cancer	0.000857	0.00144	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Fluorouracil—breast cancer	0.000856	0.00144	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Docetaxel—breast cancer	0.000852	0.00143	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Fluorouracil—breast cancer	0.000851	0.00143	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Docetaxel—breast cancer	0.000847	0.00142	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Docetaxel—breast cancer	0.000845	0.00142	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Irinotecan—breast cancer	0.000843	0.00142	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Mitoxantrone—breast cancer	0.000843	0.00142	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Capecitabine—breast cancer	0.000836	0.00141	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Paclitaxel—breast cancer	0.00083	0.0014	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Capecitabine—breast cancer	0.000825	0.00139	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Gemcitabine—breast cancer	0.000821	0.00138	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Capecitabine—breast cancer	0.00082	0.00138	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HSPA1B—breast cancer	0.000819	0.00275	CbGpPWpGaD
Glycerol Phenylbutyrate—Fatigue—Capecitabine—breast cancer	0.000819	0.00138	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CAV1—breast cancer	0.000818	0.00274	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ARHGDIA—breast cancer	0.000814	0.00273	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Epirubicin—breast cancer	0.00081	0.00136	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Fluorouracil—breast cancer	0.000807	0.00136	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Docetaxel—breast cancer	0.000802	0.00135	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Epirubicin—breast cancer	0.000799	0.00134	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MED12—breast cancer	0.000794	0.00266	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—DPYD—breast cancer	0.000794	0.00266	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FST—breast cancer	0.000793	0.00266	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Paclitaxel—breast cancer	0.000792	0.00133	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ENO1—breast cancer	0.000785	0.00263	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HEY2—breast cancer	0.000784	0.00263	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALDOA—breast cancer	0.000781	0.00262	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Capecitabine—breast cancer	0.000776	0.00131	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Docetaxel—breast cancer	0.000775	0.0013	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RPS6KB2—breast cancer	0.000774	0.0026	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RGS2—breast cancer	0.000765	0.00257	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Paclitaxel—breast cancer	0.000765	0.00129	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOA3—breast cancer	0.000759	0.00254	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL20—breast cancer	0.000757	0.00254	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC2A2—breast cancer	0.000753	0.00253	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Capecitabine—breast cancer	0.000751	0.00126	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Doxorubicin—breast cancer	0.00075	0.00126	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	0.000745	0.0025	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF3—breast cancer	0.000743	0.00249	CbGpPWpGaD
Glycerol Phenylbutyrate—Flatulence—Doxorubicin—breast cancer	0.000739	0.00124	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTR—breast cancer	0.000738	0.00247	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCG2—breast cancer	0.000738	0.00247	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CPT1A—breast cancer	0.000738	0.00247	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Paclitaxel—breast cancer	0.000736	0.00124	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FASN—breast cancer	0.000733	0.00246	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—JAG1—breast cancer	0.000733	0.00246	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TLE3—breast cancer	0.000733	0.00246	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LPAR1—breast cancer	0.000733	0.00246	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PARP1—breast cancer	0.00073	0.00245	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Paclitaxel—breast cancer	0.000729	0.00123	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Paclitaxel—breast cancer	0.000729	0.00123	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HEY1—breast cancer	0.000726	0.00243	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Paclitaxel—breast cancer	0.000725	0.00122	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HPGDS—breast cancer	0.000724	0.00243	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CALCA—breast cancer	0.000721	0.00242	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HBA1—breast cancer	0.000719	0.00241	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—RPS6—breast cancer	0.000713	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DLL1—breast cancer	0.000712	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF4—breast cancer	0.000707	0.00237	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CXCR4—breast cancer	0.000704	0.00236	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Docetaxel—breast cancer	0.000704	0.00118	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ACHE—breast cancer	0.000702	0.00235	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTT1—breast cancer	0.000702	0.00235	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HIST1H2BK—breast cancer	0.000698	0.00234	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HIST1H2BC—breast cancer	0.000698	0.00234	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC2A1—breast cancer	0.000696	0.00234	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Methotrexate—breast cancer	0.000693	0.00117	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRB7—breast cancer	0.000692	0.00232	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PDE4D—breast cancer	0.000692	0.00232	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Paclitaxel—breast cancer	0.000687	0.00116	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Capecitabine—breast cancer	0.000681	0.00115	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TAB2—breast cancer	0.00068	0.00228	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TCF7L2—breast cancer	0.000679	0.00228	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CNR2—breast cancer	0.000675	0.00226	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Docetaxel—breast cancer	0.000671	0.00113	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP17A1—breast cancer	0.000664	0.00223	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DKK1—breast cancer	0.000658	0.00221	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTGS1—breast cancer	0.000658	0.0022	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ENO1—breast cancer	0.000658	0.0022	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.000655	0.0022	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HSP90AA1—breast cancer	0.000655	0.0022	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFC—breast cancer	0.000653	0.00219	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Capecitabine—breast cancer	0.00065	0.00109	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Epirubicin—breast cancer	0.000649	0.00109	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Docetaxel—breast cancer	0.000648	0.00109	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.000647	0.00217	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP2D6—breast cancer	0.000645	0.00216	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JAG2—breast cancer	0.000644	0.00216	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PRL—breast cancer	0.000637	0.00214	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—WNT1—breast cancer	0.000634	0.00213	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOA2—breast cancer	0.000633	0.00212	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Capecitabine—breast cancer	0.000628	0.00106	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ADAM10—breast cancer	0.000628	0.0021	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Docetaxel—breast cancer	0.000624	0.00105	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Methotrexate—breast cancer	0.000622	0.00105	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Docetaxel—breast cancer	0.000618	0.00104	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Docetaxel—breast cancer	0.000618	0.00104	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Methotrexate—breast cancer	0.000614	0.00103	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Docetaxel—breast cancer	0.000614	0.00103	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—FASN—breast cancer	0.000614	0.00206	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—BCHE—breast cancer	0.000611	0.00205	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF10—breast cancer	0.000611	0.00205	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Methotrexate—breast cancer	0.00061	0.00103	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Methotrexate—breast cancer	0.000609	0.00103	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC5A5—breast cancer	0.000604	0.00202	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Capecitabine—breast cancer	0.000604	0.00102	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOTCH4—breast cancer	0.000601	0.00202	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Doxorubicin—breast cancer	0.0006	0.00101	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Capecitabine—breast cancer	0.000599	0.00101	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Capecitabine—breast cancer	0.000598	0.00101	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GZMB—breast cancer	0.000598	0.002	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Capecitabine—breast cancer	0.000595	0.001	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PDGFA—breast cancer	0.000589	0.00198	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC2A1—breast cancer	0.000583	0.00196	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NQO1—breast cancer	0.000583	0.00196	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Docetaxel—breast cancer	0.000582	0.00098	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Epirubicin—breast cancer	0.000582	0.00098	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFBR2—breast cancer	0.000581	0.00195	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AGTR2—breast cancer	0.00058	0.00194	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL2—breast cancer	0.00058	0.00194	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Methotrexate—breast cancer	0.000578	0.000972	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Epirubicin—breast cancer	0.000575	0.000967	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTHLH—breast cancer	0.000574	0.00192	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BMP2—breast cancer	0.000574	0.00192	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ITPR1—breast cancer	0.000572	0.00192	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.000571	0.00191	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Epirubicin—breast cancer	0.000571	0.000961	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Epirubicin—breast cancer	0.00057	0.000959	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP3A4—breast cancer	0.000569	0.00191	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ERBB4—breast cancer	0.000568	0.0019	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT5A—breast cancer	0.000568	0.0019	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000566	0.0019	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Capecitabine—breast cancer	0.000564	0.000949	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP1B1—breast cancer	0.000559	0.00187	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Methotrexate—breast cancer	0.000559	0.00094	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EDNRB—breast cancer	0.000556	0.00186	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PGR—breast cancer	0.00055	0.00184	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SMAD4—breast cancer	0.00055	0.00184	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSP90AA1—breast cancer	0.000548	0.00184	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—THBS1—breast cancer	0.000547	0.00183	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Epirubicin—breast cancer	0.000541	0.00091	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Doxorubicin—breast cancer	0.000539	0.000906	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HES1—breast cancer	0.000537	0.0018	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NCOR1—breast cancer	0.000534	0.00179	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOA1—breast cancer	0.000533	0.00179	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Doxorubicin—breast cancer	0.000532	0.000895	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000528	0.000889	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF1—breast cancer	0.000528	0.00177	CbGpPWpGaD
Glycerol Phenylbutyrate—Fatigue—Doxorubicin—breast cancer	0.000528	0.000888	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—STK11—breast cancer	0.000526	0.00176	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP19A1—breast cancer	0.000526	0.00176	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NRG1—breast cancer	0.000524	0.00176	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Epirubicin—breast cancer	0.000523	0.00088	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FLT1—breast cancer	0.000522	0.00175	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—H2AFX—breast cancer	0.00052	0.00174	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF3—breast cancer	0.00052	0.00174	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SQSTM1—breast cancer	0.00052	0.00174	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JAG1—breast cancer	0.000513	0.00172	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOTCH3—breast cancer	0.000511	0.00171	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PARP1—breast cancer	0.000511	0.00171	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Methotrexate—breast cancer	0.000507	0.000853	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CALCA—breast cancer	0.000505	0.00169	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ERCC2—breast cancer	0.000502	0.00168	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Doxorubicin—breast cancer	0.0005	0.000842	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RPS6—breast cancer	0.000499	0.00167	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF4—breast cancer	0.000495	0.00166	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTEN—breast cancer	0.000494	0.00165	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL12—breast cancer	0.000493	0.00165	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCR4—breast cancer	0.000493	0.00165	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ERBB3—breast cancer	0.000491	0.00165	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGFR2—breast cancer	0.00049	0.00164	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—COMT—breast cancer	0.000489	0.00164	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTP1—breast cancer	0.000486	0.00163	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PAK1—breast cancer	0.000484	0.00162	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Doxorubicin—breast cancer	0.000484	0.000814	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Methotrexate—breast cancer	0.000484	0.000814	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HMOX1—breast cancer	0.00048	0.00161	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ITPR1—breast cancer	0.000479	0.0016	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TCF7L2—breast cancer	0.000476	0.00159	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Epirubicin—breast cancer	0.000475	0.000798	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—MTHFR—breast cancer	0.000472	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TERT—breast cancer	0.00047	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Methotrexate—breast cancer	0.000467	0.000786	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCB1—breast cancer	0.00046	0.00154	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOTCH2—breast cancer	0.000459	0.00154	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HSP90AA1—breast cancer	0.000459	0.00154	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGFR1—breast cancer	0.000457	0.00153	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Epirubicin—breast cancer	0.000453	0.000761	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TYMS—breast cancer	0.000452	0.00152	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HIF1A—breast cancer	0.00045	0.00151	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Methotrexate—breast cancer	0.000449	0.000756	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOR1—breast cancer	0.000447	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTM1—breast cancer	0.000447	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PLA2G4A—breast cancer	0.000447	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRL—breast cancer	0.000446	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AGTR1—breast cancer	0.000446	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Methotrexate—breast cancer	0.000446	0.00075	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Methotrexate—breast cancer	0.000445	0.000749	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Methotrexate—breast cancer	0.000443	0.000745	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STK11—breast cancer	0.00044	0.00147	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADAM10—breast cancer	0.00044	0.00147	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Doxorubicin—breast cancer	0.000439	0.000739	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Epirubicin—breast cancer	0.000437	0.000736	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CAV1—breast cancer	0.000435	0.00146	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PLG—breast cancer	0.000435	0.00146	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GPX1—breast cancer	0.000428	0.00144	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF10—breast cancer	0.000428	0.00143	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP1A1—breast cancer	0.000424	0.00142	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Epirubicin—breast cancer	0.000421	0.000708	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ERCC2—breast cancer	0.00042	0.00141	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Methotrexate—breast cancer	0.00042	0.000706	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Doxorubicin—breast cancer	0.000419	0.000705	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Epirubicin—breast cancer	0.000417	0.000702	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Epirubicin—breast cancer	0.000417	0.000701	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Epirubicin—breast cancer	0.000414	0.000697	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PDGFA—breast cancer	0.000413	0.00138	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS2—breast cancer	0.000409	0.00137	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFBR2—breast cancer	0.000407	0.00136	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOTCH1—breast cancer	0.000405	0.00136	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Doxorubicin—breast cancer	0.000405	0.000681	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ITPR1—breast cancer	0.0004	0.00134	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT5A—breast cancer	0.000398	0.00133	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP3—breast cancer	0.000398	0.00133	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ERBB4—breast cancer	0.000398	0.00133	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APC—breast cancer	0.000396	0.00133	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—KIT—breast cancer	0.000396	0.00133	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTHFR—breast cancer	0.000395	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Epirubicin—breast cancer	0.000393	0.000661	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—EGF—breast cancer	0.000392	0.00131	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Doxorubicin—breast cancer	0.000389	0.000655	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Doxorubicin—breast cancer	0.000386	0.000649	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Doxorubicin—breast cancer	0.000386	0.000649	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SMAD4—breast cancer	0.000385	0.00129	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Doxorubicin—breast cancer	0.000383	0.000645	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF1R—breast cancer	0.000383	0.00128	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HES1—breast cancer	0.000376	0.00126	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PLA2G4A—breast cancer	0.000374	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NCOR1—breast cancer	0.000374	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—BRAF—breast cancer	0.000373	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF1—breast cancer	0.00037	0.00124	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CSF2—breast cancer	0.00037	0.00124	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NRG1—breast cancer	0.000367	0.00123	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CAV1—breast cancer	0.000364	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—H2AFX—breast cancer	0.000364	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Doxorubicin—breast cancer	0.000364	0.000612	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT2—breast cancer	0.000363	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—E2F1—breast cancer	0.000362	0.00121	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CD—breast cancer	0.000348	0.00117	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	0.000348	0.00117	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SPP1—breast cancer	0.000348	0.00117	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SERPINE1—breast cancer	0.000345	0.00116	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ERBB3—breast cancer	0.000344	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGFR2—breast cancer	0.000343	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CG—breast cancer	0.000332	0.00111	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TERT—breast cancer	0.000329	0.0011	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS3—breast cancer	0.000329	0.0011	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGFR1—breast cancer	0.00032	0.00107	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HIF1A—breast cancer	0.000315	0.00106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MDM2—breast cancer	0.000312	0.00105	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—RAF1—breast cancer	0.000311	0.00104	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ERBB2—breast cancer	0.000308	0.00103	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LEP—breast cancer	0.000308	0.00103	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CAV1—breast cancer	0.000305	0.00102	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CB—breast cancer	0.000304	0.00102	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTOR—breast cancer	0.000304	0.00102	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CD4—breast cancer	0.000303	0.00102	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KDR—breast cancer	0.000301	0.00101	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTGS2—breast cancer	0.000301	0.00101	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ESR1—breast cancer	0.000294	0.000984	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CD—breast cancer	0.000292	0.000978	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FN1—breast cancer	0.00029	0.000972	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALB—breast cancer	0.000288	0.000966	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NFKBIA—breast cancer	0.000287	0.000961	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN1B—breast cancer	0.000285	0.000956	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOTCH1—breast cancer	0.000284	0.000952	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APC—breast cancer	0.000278	0.000931	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CG—breast cancer	0.000278	0.000931	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KIT—breast cancer	0.000278	0.000931	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NOS3—breast cancer	0.000276	0.000924	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EGF—breast cancer	0.000274	0.00092	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CTNNB1—breast cancer	0.000269	0.000903	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN1A—breast cancer	0.000263	0.000882	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTEN—breast cancer	0.000262	0.00088	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BRAF—breast cancer	0.000261	0.000875	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CB—breast cancer	0.000254	0.000853	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF1—breast cancer	0.000254	0.000852	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT2—breast cancer	0.000254	0.000851	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTGS2—breast cancer	0.000252	0.000845	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CD—breast cancer	0.000244	0.000818	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SRC—breast cancer	0.000243	0.000816	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SERPINE1—breast cancer	0.000241	0.000809	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT3—breast cancer	0.000235	0.000787	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOS3—breast cancer	0.00023	0.000773	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MAPK3—breast cancer	0.000224	0.000752	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTEN—breast cancer	0.00022	0.000737	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MDM2—breast cancer	0.000219	0.000733	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MYC—breast cancer	0.000218	0.000731	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RAF1—breast cancer	0.000218	0.00073	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFB1—breast cancer	0.000218	0.000729	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RELA—breast cancer	0.000217	0.000727	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ERBB2—breast cancer	0.000216	0.000723	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EGFR—breast cancer	0.000213	0.000715	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MTOR—breast cancer	0.000213	0.000713	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CB—breast cancer	0.000213	0.000713	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL8—breast cancer	0.000204	0.000685	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—KRAS—breast cancer	0.000202	0.000676	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN1B—breast cancer	0.0002	0.000669	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CASP3—breast cancer	0.000196	0.000656	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL2—breast cancer	0.000195	0.000655	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCND1—breast cancer	0.00019	0.000638	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—JUN—breast cancer	0.00019	0.000637	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CTNNB1—breast cancer	0.000189	0.000632	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CA—breast cancer	0.000185	0.000621	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP9—breast cancer	0.000185	0.00062	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN1A—breast cancer	0.000184	0.000618	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTEN—breast cancer	0.000184	0.000616	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK8—breast cancer	0.00018	0.000603	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HRAS—breast cancer	0.000171	0.000574	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SRC—breast cancer	0.00017	0.000571	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFA—breast cancer	0.000166	0.000557	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT3—breast cancer	0.000164	0.000551	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6—breast cancer	0.000164	0.00055	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK3—breast cancer	0.000157	0.000526	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CA—breast cancer	0.000155	0.00052	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MYC—breast cancer	0.000153	0.000512	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFB1—breast cancer	0.000152	0.000511	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT1—breast cancer	0.000151	0.000507	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EGFR—breast cancer	0.000149	0.000501	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KRAS—breast cancer	0.000141	0.000473	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CA—breast cancer	0.00013	0.000435	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKT1—breast cancer	0.000127	0.000425	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TP53—breast cancer	0.000125	0.000421	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HRAS—breast cancer	0.00012	0.000402	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6—breast cancer	0.000115	0.000385	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT1—breast cancer	0.000106	0.000355	CbGpPWpGaD
